System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma

Table 1

Clinical features of the hepatocellular carcinoma patients in this work.

	TCGA cohort
No. of patients	365
Age (median, range)	61(16-90)
Gender (%)
Male	246(67.4%)
Female	119(32.6%)
Stage (%)
I	170(46.6%)
ΙΙ	84(23%)
III	83(22.7%)
IV	4(1.1%)
unknown	24(6.6%)
Survival status (%)
Living	235(64.4%)
Death	130(35.6%)
OS days (median, range)	594(1-3675)